NCT00258843View on ClinicalTrials.gov

Safety of Imovax Polio in Chinese Infants and Children

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

April 30, 2006

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Inactivated Poliomyelitis vaccine

0.5 mL, intramuscular (IM)

BIOLOGICAL

Inactivated Poliomyelitis vaccine

0.5 mL, IM

Trial Locations (1)

Unknown

Pingle

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00258843 - Safety of Imovax Polio in Chinese Infants and Children | Biotech Hunter | Biotech Hunter